With the study presented here, we wanted to give first insights into the immune cell distribution in HNSCC and a possible explanation for a high TGF-β expression being associated with worse outcomes of anti-PD-1 treatment in HNSCC. Here, TGFB1 is linked to head and neck squamous cell carcinoma.